Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients

NCT02758730 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

BIOLOGICAL: AFFITOPE® PD01A + Adjuvant
BIOLOGICAL: Adjuvant without active component

Sponsor

Affiris AG

Collaborators

[object Object]